NxThera Lands $9,000,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=242e7f0c-5494-4953-80f4-3bc4ae22f589&Preview=1 -
Date
10/5/2011 -
Company Name
NxThera -
Mailing Address
4186 Lexington Ave. St. Paul, MN 55126 -
Company Description
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. -
Website
http://www.nxthera.com -
Transaction Type
Venture Equity -
Transaction Amount
$9,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Funds raised will be used to obtain European CE Mark approval and U.S. Food and Drug Administration clearance for a clinical study for the Rezum vapor ablation device in Europe, Canada and the United States, and to develop additional endourology devices. -
M&A Terms
-
Venture Investor
American Medical Systems -
Venture Investor
Mitsui & Co. Venture Partners -
Venture Investor
Prolog Ventures -
Venture Investor
Alafi Capital
